BAVARIAN NORDIC Gross Profit 2016-2019 | BVNRY

BAVARIAN NORDIC gross profit from 2016 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
BAVARIAN NORDIC Annual Gross Profit
(Millions of US $)
2018 $39
2017 $164
2016 $105
2015 $90
BAVARIAN NORDIC Quarterly Gross Profit
(Millions of US $)
Q3 2019 $8
Q2 2019 $8
Q1 2019 $8
Q4 2018 $12
Q3 2018 $22
Q2 2018 $7
Q1 2018 $-1
Q4 2017 $2
Q3 2017 $100
Q2 2017 $40
Q1 2017 $21
Q4 2016 $45
Q3 2016 $46
Q2 2016 $13
Q1 2016 $1
Q4 2015 $47
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.050B $0.079B
Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company's product pipeline consists of IMVAMUNE(R), PROSTVAC (R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical trial stage. Bavarian Nordic A/S is headquartered in Kvistgaard, Denmark.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $124.084B 14.19
CSL (CSLLY) Australia $95.484B 0.00
Gilead Sciences (GILD) United States $88.687B 11.42
Vertex Pharmaceuticals (VRTX) United States $59.632B 54.12
Biogen (BIIB) United States $56.416B 9.63
Regeneron Pharmaceuticals (REGN) United States $48.666B 20.61
Illumina (ILMN) United States $39.683B 41.03
Alexion Pharmaceuticals (ALXN) United States $21.285B 9.90
Seattle Genetics (SGEN) United States $19.359B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.724B 0.00
Incyte (INCY) United States $16.761B 35.96
BioMarin Pharmaceutical (BMRN) United States $16.346B 0.00
Genmab (GNMSF) Denmark $14.867B 47.82
Alnylam Pharmaceuticals (ALNY) United States $13.430B 0.00
Galapagos (GLPG) Belgium $13.052B 33.63
Exact Sciences (EXAS) United States $12.804B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.564B 54.03
BeiGene (BGNE) Cayman Islands $9.685B 0.00
Sarepta Therapeutics (SRPT) United States $8.482B 0.00
Moderna (MRNA) United States $7.996B 0.00
QIAGEN (QGEN) Netherlands $7.888B 24.29
Bio-Techne Corp (TECH) United States $7.580B 51.87
BioNTech SE (BNTX) Germany $7.566B 0.00
Guardant Health (GH) United States $7.117B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.346B 16.13
ACADIA Pharmaceuticals (ACAD) United States $6.264B 0.00
Amarin (AMRN) Ireland $6.251B 0.00
Ascendis Pharma (ASND) Denmark $6.218B 0.00
Reata Pharmaceuticals (RETA) United States $5.939B 0.00
Exelixis (EXEL) United States $5.895B 19.02
ARGENX SE-ADR (ARGX) Netherlands $5.850B 0.00
Acceleron Pharma (XLRN) United States $4.681B 0.00
China Biologic Products (CBPO) China $4.566B 25.72
Repligen (RGEN) United States $4.423B 80.91
Bluebird Bio (BLUE) United States $4.044B 0.00
Adaptive Biotechnologies (ADPT) United States $3.730B 0.00
MorphoSys AG (MOR) Germany $3.611B 0.00
Mirati Therapeutics (MRTX) United States $3.338B 0.00
Zai Lab (ZLAB) China $3.214B 0.00
Blueprint Medicines (BPMC) United States $3.202B 0.00
Immunomedics (IMMU) United States $3.179B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.172B 0.00
Alkermes (ALKS) Ireland $3.145B 249.13
Genmab (GMAB) Denmark $3.130B 12.28
Emergent Biosolutions (EBS) United States $3.093B 21.63
NeoGenomics (NEO) United States $3.076B 163.67
Momenta Pharmaceuticals (MNTA) United States $3.050B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.036B 51.43
MyoKardia (MYOK) United States $2.974B 0.00
Halozyme Therapeutics (HALO) United States $2.875B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.772B 0.00
Amicus Therapeutics (FOLD) United States $2.500B 0.00
Arena Pharmaceuticals (ARNA) United States $2.395B 5.57
UniQure (QURE) Netherlands $2.378B 0.00
Insmed (INSM) United States $2.353B 0.00
Fate Therapeutics (FATE) United States $2.296B 0.00
RA PHARMCTL INC (RARX) United States $2.200B 0.00
Denali Therapeutics (DNLI) United States $2.120B 0.00
Principia Biopharma (PRNB) United States $2.089B 0.00
Epizyme (EPZM) United States $1.957B 0.00
Alector (ALEC) United States $1.888B 0.00
REGENXBIO (RGNX) United States $1.750B 0.00
Ligand Pharmaceuticals (LGND) United States $1.746B 50.99
Arvinas (ARVN) United States $1.620B 0.00
Akcea Therapeutics (AKCA) United States $1.606B 37.17
Zymeworks (ZYME) Canada $1.592B 0.00
Coherus BioSciences (CHRS) United States $1.494B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.396B 0.00
Zealand Pharma (ZEAL) Denmark $1.367B 0.00
Myriad Genetics (MYGN) United States $1.341B 23.67
Nabriva Therapeutics AG (NBRV) Ireland $1.333B 0.00
Intra-Cellular Therapies (ITCI) United States $1.276B 0.00
Editas Medicine (EDIT) United States $1.153B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.149B 0.00
Twist Bioscience (TWST) United States $1.124B 0.00
Revance Therapeutics (RVNC) United States $1.117B 0.00
Athenex (ATNX) United States $1.009B 0.00
PHARMA MAR SA (PHMMF) Spain $0.941B 0.00
Cytokineticsorporated (CYTK) United States $0.870B 0.00
DBV Technologies S.A (DBVT) France $0.860B 0.00
Pharming Group (PHGUF) Netherlands $0.857B 0.00
Adverum Biotechnologies (ADVM) United States $0.849B 0.00
Mesoblast (MESO) Australia $0.827B 0.00
Sangamo Therapeutics (SGMO) United States $0.788B 0.00
Heska (HSKA) United States $0.781B 0.00
Codexis (CDXS) United States $0.758B 0.00
Vericel (VCEL) United States $0.746B 111.27
Intrexon (PGEN) United States $0.706B 0.00
ANI Pharmaceuticals (ANIP) United States $0.698B 11.90
Cellectis S.A (CLLS) France $0.694B 0.00
Arcus Biosciences (RCUS) United States $0.682B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Cara Therapeutics (CARA) United States $0.640B 0.00
Retrophin (RTRX) United States $0.621B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.612B 5.41
Anika Therapeutics (ANIK) United States $0.608B 20.78
UROGEN PHARMA (URGN) United States $0.599B 0.00
Cel-Sci (CVM) United States $0.596B 0.00
Intellia Therapeutics (NTLA) United States $0.592B 0.00
GENFIT S.A (GNFT) France $0.591B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.579B 0.00
Kadmon Holdings (KDMN) United States $0.558B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.523B 0.00
Bellus Health (BLU) Canada $0.513B 0.00
AC Immune SA (ACIU) Switzerland $0.493B 11.39
Prothena (PRTA) Ireland $0.485B 0.00
NantKwest (NK) United States $0.481B 0.00
Compugen (CGEN) Israel $0.464B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
BioDelivery Sciences (BDSI) United States $0.457B 0.00
Puma Biotechnology (PBYI) United States $0.441B 0.00
Clovis Oncology (CLVS) United States $0.438B 0.00
Cue Biopharma (CUE) United States $0.434B 0.00
Mersana Therapeutics (MRSN) United States $0.430B 0.00
AnaptysBio (ANAB) United States $0.423B 0.00
Agenus (AGEN) United States $0.408B 0.00
Precision BioSciences (DTIL) United States $0.407B 0.00
Kindred Biosciences (KIN) United States $0.406B 0.00
Merus (MRUS) Netherlands $0.405B 0.00
Pfenex (PFNX) United States $0.401B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.60
Inovio Pharmaceuticals (INO) United States $0.379B 0.00
Sorrento Therapeutics (SRNE) United States $0.378B 0.00
Avid Bioservices (CDMO) United States $0.377B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.375B 0.00
Dynavax Technologies (DVAX) United States $0.370B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.366B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.358B 0.00
Cellular Biomedicine (CBMG) United States $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.322B 0.00
Gritstone Oncology (GRTS) United States $0.319B 0.00
Stemline Therapeutics (STML) United States $0.316B 0.00
Albireo Pharma (ALBO) United States $0.308B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.303B 2.10
WAVE Life Sciences (WVE) Singapore $0.285B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.279B 0.00
MannKind (MNKD) United States $0.279B 0.00
Aduro Biotech (ADRO) United States $0.279B 0.00
Starpharma Holdings (SPHRY) Australia $0.276B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.270B 0.00
Kamada (KMDA) Israel $0.268B 11.13
Syros Pharmaceuticals (SYRS) United States $0.267B 0.00
OSMOTICA PHARM (OSMT) United States $0.265B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.262B 0.00
Novavax (NVAX) United States $0.255B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.235B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
Protagonist Therapeutics (PTGX) United States $0.233B 0.00
IVERIC Bio (ISEE) United States $0.230B 0.00
Geron (GERN) United States $0.230B 0.00
Kala Pharmaceuticals (KALA) United States $0.225B 0.00
VBI Vaccines (VBIV) United States $0.223B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
XOMA (XOMA) United States $0.219B 0.00
Prometic Life Sciences (LMNL) Canada $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.210B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.210B 0.00
Alcobra (ARCT) United States $0.208B 0.00
TELA Bio (TELA) United States $0.202B 0.00
Abeona Therapeutics (ABEO) United States $0.199B 0.00
ADMA Biologics Inc (ADMA) United States $0.198B 0.00
ChromaDex (CDXC) United States $0.195B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.193B 9.92
Athersys (ATHX) United States $0.193B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.192B 0.00
Arbutus Biopharma (ABUS) Canada $0.186B 0.00
Theratechnologies (THTX) Canada $0.186B 0.00
Cerecor (CERC) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.179B 0.00
Five Prime Therapeutics (FPRX) United States $0.177B 0.00
Affimed (AFMD) Germany $0.177B 0.00
VTv Therapeutics (VTVT) United States $0.173B 0.00
Exicure (XCUR) United States $0.173B 0.00
VolitionRX (VNRX) Singapore $0.172B 0.00
Fortress Biotech (FBIO) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.164B 0.00
Selecta Biosciences (SELB) United States $0.151B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.147B 0.00
Verastem (VSTM) United States $0.146B 0.00
Dyadic (DYAI) United States $0.145B 0.00
CorMedix Inc (CRMD) United States $0.144B 0.00
Strongbridge Biopharma (SBBP) United States $0.144B 0.00
Aptinyx (APTX) United States $0.142B 0.00
Northwest Biotherapeutics (NWBO) United States $0.141B 0.00
Liquidia Technologies (LQDA) United States $0.137B 0.00
Antibe Therapeutics (ATBPF) Canada $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Celyad SA (CYAD) Belgium $0.133B 0.00
ARAVIVE, INC (ARAV) United States $0.131B 0.00
Arsanis (XFOR) United States $0.130B 0.00
Palatin Technologies (PTN) United States $0.128B 3.48
PHASEBIO PHARMA (PHAS) United States $0.125B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.120B 0.00
OvaScience (MLND) United States $0.116B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.115B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
Happiness Biotech Group (HAPP) China $0.114B 0.00
Clearside Biomedical (CLSD) United States $0.114B 0.00
Menlo Therapeutics (MNLO) United States $0.107B 0.00
Prima BioMed (IMMP) Australia $0.106B 0.00
Vaccinex (VCNX) United States $0.099B 0.00
AIT Therapeutics (XAIR) United States $0.095B 0.00
Proteostasis Therapeutics (PTI) United States $0.093B 0.00
Checkpoint Therapeutics (CKPT) United States $0.091B 0.00
Applied Genetic Technologies (AGTC) United States $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
SESEN BIO, INC (SESN) United States $0.082B 0.00
Emmaus Life Sciences (EMMA) United States $0.080B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.079B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Catalyst Biosciences (CBIO) United States $0.075B 0.00
Pluristem Therapeutics (PSTI) Israel $0.072B 0.00
Orgenesis (ORGS) United States $0.068B 4.40
ANIXA BIOSCIENCES INC (ANIX) United States $0.067B 0.00
Acorda Therapeutics (ACOR) United States $0.066B 0.00
Trevena (TRVN) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.065B 0.00
Soligenix (SNGX) United States $0.062B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.061B 0.00
DiaMedica Therapeutics (DMAC) United States $0.060B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
NewLink Genetics (NLNK) United States $0.055B 0.00
Advaxis (ADXS) United States $0.053B 0.00
Protalix BioTherapeutics (PLX) Israel $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Curis (CRIS) United States $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
AquaBounty Technologies (AQB) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
TOCAGEN INC (TOCA) United States $0.042B 0.00
Organovo Holdings (ONVO) United States $0.040B 0.00
AmpliPhi Biosciences (ARMP) United States $0.038B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.030B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Celsion (CLSN) United States $0.026B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Oncobiologics (OTLK) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
IBio (IBIO) United States $0.024B 0.00
VIVUS (VVUS) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Cesca Therapeutics (THMO) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00